31
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
Condition(s):Graft Versus Host Disease; Nonneoplastic ConditionLast Updated:August 26, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):Graft Versus Host Disease; Nonneoplastic ConditionLast Updated:August 26, 2013Unknown status
Condition(s):Pediatric ALLLast Updated:December 8, 2023Recruiting
Condition(s):Cytomegalovirus InfectionLast Updated:January 25, 2018Completed
Condition(s):Cytomegalovirus InfectionsLast Updated:November 9, 2022Recruiting
Condition(s):Cytomegalovirus InfectionLast Updated:January 25, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.